{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T13:54:32Z","timestamp":1753883672251,"version":"3.41.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:p>Dermatopathic lymphadenopathy (DL) is a distinctive type of lymph node hyperplasia that typically occurs in the setting of chronic dermatologic diseases. DL generally self-resolves following disappearance of the underlying skin stimulus and does not require any specific therapy. We recently observed multiple myeloma oncogene 1\/interferon regulatory factor 4 (MUM1\/IRF4) expression in a case of DL using immunohistochemical methods. The goal of this study was to systematically assess DL cases for MUM1\/IRF4 expression and to survey other histiocytic and Langerhans cell lesions. We particularly focused on Langerhans cell histiocytosis (LCH) because the differential diagnosis of DL versus LCH in lymph nodes can be challenging. We identified high expression of MUM1\/IRF4 in all 22 cases of DL tested. Specifically, MUM1\/IRF4+ dendritic cells comprised 50% to 90% (median, 80%) of all dendritic cells in the paracortex of dermatopathic lymph nodes, always showing moderate or strong intensity. Among 10 DL cases stained for MUM1\/IRF4 and langerin\/CD207 using dual immunohistochemistry, MUM1\/IRF4+ and langerin+ Langerhans cells represented 5% to 60% (median, 30%) of paracortical dendritic cells. MUM1\/IRF4 was also positive in reactive Langerhans cells in skin biopsy specimens of all cases of spongiotic dermatitis (n=10) and normal skin (n=15), and was negative in all cases of LCH (n=24), Rosai-Dorfman disease (n=10), follicular dendritic cell sarcoma (n=5) and histiocytic sarcoma (n=4). In aggregate, our findings support the utility of MUM1\/IRF4 to highlight the dendritic cells of DL and to distinguish DL from other histiocytic and Langerhans cells lesions.<\/jats:p>","DOI":"10.1097\/pas.0000000000001935","type":"journal-article","created":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T17:00:13Z","timestamp":1658768413000},"page":"1514-1523","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["MUM1\/IRF4 is Highly Expressed in Dermatopathic Lymphadenopathy"],"prefix":"10.1097","volume":"46","author":[{"given":"Sofia","family":"Garces","sequence":"first","affiliation":[{"name":"Department of Hematopathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zbigniew","family":"Rudzki","sequence":"additional","affiliation":[{"name":"Department of Histopathology, Birmingham Heartlands Hospitals, University of Birmingham Hospitals NHS Foundation Trust, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Cameron","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Hematopathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto N.","family":"Miranda","sequence":"additional","affiliation":[{"name":"Department of Hematopathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana M.","family":"Medina","sequence":"additional","affiliation":[{"name":"Department of Pathology, Mount Sinai Medical Center, Miami, FL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vathany","family":"Sriganeshan","sequence":"additional","affiliation":[{"name":"Department of Pathology, Mount Sinai Medical Center, Miami, FL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Branko","family":"Cuglievan","sequence":"additional","affiliation":[{"name":"Division of Pediatric Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaoying","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hematopathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Hematopathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima","family":"Jelloul","sequence":"additional","affiliation":[{"name":"Department of Hematopathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph D.","family":"Khoury","sequence":"additional","affiliation":[{"name":"Department of Hematopathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beenu","family":"Thakral","sequence":"additional","affiliation":[{"name":"Department of Hematopathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guilin","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Hematopathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan C.","family":"Garces","sequence":"additional","affiliation":[{"name":"Department of Pathology, Instituto Oncol\u00f3gico Nacional Dr. Juan Tanca Marengo, Guayaquil, Ecuador"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[{"name":"Department of Hematopathology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,7,26]]},"reference":[{"key":"R1-20250612","first-page":"257","article-title":"Contribution a l\u2019\u00e9tude de l\u2019histo-physiologie cutan\u00e9e: a propos d\u2019un aspect histo-pathologique nouveau du ganglion lymphatique: r\u00e9ticulose lipo-m\u00e9lanique accompagnant certainesdermatoses g\u00e9n\u00e9ralis\u00e9es. Les \u00e9changes entre la peau et le ganglion (Contribution to cutaneous histopathology. A new histopathological aspect of the lymph node: Lipomelanotic reticulosis association with generalized dermatoses. Exchanges between the skin and the lymph node)","volume":"8","author":"Pautrier","year":"1937","journal-title":"Ann Dermatol Syphiligr"},{"key":"R2-20250612","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/s41379-019-0440-4","article-title":"Clinical, histopathologic, and immunoarchitectural features of dermatopathic lymphadenopathy: an update","volume":"33","author":"Garces","year":"2020","journal-title":"Mod Pathol"},{"key":"R4-20250612","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/imm.12888","article-title":"Human dendritic cell subsets: an update","volume":"154","author":"Collin","year":"2018","journal-title":"Immunology"},{"key":"R5-20250612","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1084\/jem.20020018","article-title":"Accumulation of immature Langerhans cells in human lymph nodes draining chronically inflamed skin","volume":"196","author":"Geissmann","year":"2002","journal-title":"J Exp Med"},{"key":"R6-20250612","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1084\/jem.20111457","article-title":"Characterization of resident and migratory dendritic cells in human lymph nodes","volume":"209","author":"Segura","year":"2012","journal-title":"J Exp Med"},{"key":"R7-20250612","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/BF02889443","article-title":"Langerhans cells and interdigitating reticulum cells in the thymus-dependent region in human dermatopathic lymphadenitis","volume":"25","author":"Rausch","year":"1977","journal-title":"Virchows Arch B Cell Pathol"},{"key":"R8-20250612","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1182\/blood-2008-06-165266","article-title":"Distinctive localization of antigen-presenting cells in human lymph nodes","volume":"113","author":"Angel","year":"2009","journal-title":"Blood"},{"key":"R9-20250612","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1002\/ccr3.1663","article-title":"Florid dermatopathic lymphadenopathy\u2014a morphological mimic of Langerhans cell histiocytosis","volume":"6","author":"Ravindran","year":"2018","journal-title":"Clin Case Rep"},{"key":"R10-20250612","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.6004\/jnccn.2021.7098","article-title":"Challenges in the histopathologic diagnosis of histiocytic neoplasms","volume":"19","author":"Rech","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"R11-20250612","first-page":"256","article-title":"Dermatopathic lymphadenopathy. An immunophenotypic comparison of cases associated and unassociated with mycosis fungoides","volume":"123","author":"Burke","year":"1986","journal-title":"Am J Pathol"},{"key":"R12-20250612","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1084\/jem.20130930","article-title":"Langerhans cells are generated by two distinct PU.1-dependent transcriptional networks","volume":"210","author":"Chopin","year":"2013","journal-title":"J Exp Med"},{"key":"R13-20250612","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41467-019-14125-x","article-title":"Genomic programming of IRF4-expressing human Langerhans cells","volume":"11","author":"Sirvent","year":"2020","journal-title":"Nat Commun"},{"key":"R14-20250612","doi-asserted-by":"crossref","first-page":"665312","DOI":"10.3389\/fimmu.2021.665312","article-title":"An IRF1-IRF4 Toggle-Switch Controls Tolerogenic and Immunogenic Transcriptional Programming in Human Langerhans Cells","volume":"12","author":"Davies","year":"2021","journal-title":"Front Immunol"},{"key":"R15-20250612","doi-asserted-by":"crossref","first-page":"e2100072","DOI":"10.1002\/bies.202100072","article-title":"Switching between tolerance and immunity: do counter-acting gene networks dictate Langerhans cell function in the skin?","volume":"43","author":"Bennett","year":"2021","journal-title":"Bioessays"},{"key":"R16-20250612","doi-asserted-by":"crossref","first-page":"e2000182","DOI":"10.1002\/bies.202000182","article-title":"Tolerogenic and immunogenic states of Langerhans cells are orchestrated by epidermal signals acting on a core maturation gene module","volume":"43","author":"Polak","year":"2021","journal-title":"Bioessays"},{"key":"R17-20250612","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10024-004-3027-z","article-title":"Langerin (CD207) staining in normal pediatric tissues, reactive lymph nodes, and childhood histiocytic disorders","volume":"7","author":"Chikwava","year":"2004","journal-title":"Pediatr Dev Pathol"},{"key":"R18-20250612","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0300-9084(99)80017-0","article-title":"The role of interferon regulatory factors in the interferon system and cell growth control","volume":"80","author":"Harada","year":"1998","journal-title":"Biochimie"},{"key":"R19-20250612","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1093\/nar\/23.12.2127","article-title":"Molecular cloning of LSIRF, a lymphoid-specific member of the interferon regulatory factor family that binds the interferon-stimulated response element (ISRE)","volume":"23","author":"Matsuyama","year":"1995","journal-title":"Nucleic Acids Res"},{"key":"R20-20250612","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1128\/MCB.16.4.1283","article-title":"A novel interferon regulatory factor family transcription factor, ICSAT\/Pip\/LSIRF, that negatively regulates the activity of interferon-regulated genes","volume":"16","author":"Yamagata","year":"1996","journal-title":"Mol Cell Biol"},{"key":"R21-20250612","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/ng1097-226","article-title":"Deregulation of MUM1\/IRF4 by chromosomal translocation in multiple myeloma","volume":"17","author":"Iida","year":"1997","journal-title":"Nat Genet"},{"key":"R22-20250612","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1158\/1078-0432.CCR-08-1845","article-title":"IRF4: immunity. Malignancy! Therapy?","volume":"15","author":"Shaffer","year":"2009","journal-title":"Clin Cancer Res"},{"key":"R23-20250612","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.4049\/jimmunol.174.5.2573","article-title":"IFN regulatory factor-4 and -8 govern dendritic cell subset development and their functional diversity","volume":"174","author":"Tamura","year":"2018","journal-title":"J Immunol"},{"key":"R24-20250612","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/PAS.0000000000000129","article-title":"BRAF V600E expression in Langerhans cell histiocytosis: clinical and immunohistochemical study on 25 pulmonary and 54 extrapulmonary cases","volume":"38","author":"Roden","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R25-20250612","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1182\/blood-2012-06-429597","article-title":"BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis","volume":"120","author":"Sahm","year":"2012","journal-title":"Blood"},{"key":"R26-20250612","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/PAS.0000000000000897","article-title":"Cyclin D1 is expressed in neoplastic cells of langerhans cell histiocytosis but not reactive langerhans cell proliferations","volume":"41","author":"Shanmugam","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R27-20250612","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/PAP.0000000000000241","article-title":"Utility of cyclin D1 in the diagnostic workup of hematopoietic neoplasms: what can cyclin D1 do for us?","volume":"26","author":"Wang","year":"2019","journal-title":"Adv Anat Pathol"},{"key":"R28-20250612","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.humpath.2021.12.013","article-title":"Cyclin D1 expression in Rosai-Dorfman disease: a near-constant finding that is not invariably associated with mitogen-activated protein kinase\/extracellular signal-regulated kinase pathway activation","volume":"121","author":"Garces","year":"2022","journal-title":"Hum Pathol"},{"key":"R29-20250612","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.humpath.2007.03.015","article-title":"Lymph node involvement by Langerhans cell histiocytosis: a clinicopathologic and immunohistochemical study of 20 cases","volume":"38","author":"Edelweiss","year":"2007","journal-title":"Hum Pathol"},{"key":"R30-20250612","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1158\/2326-6066.CIR-19-0232","article-title":"CSF1R is required for differentiation and migration of langerhans cells and langerhans cell histiocytosis","volume":"8","author":"Lonardi","year":"2020","journal-title":"Cancer Immunol Res"},{"key":"R31-20250612","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1182\/blood.V97.5.1241","article-title":"Differentiation of Langerhans cells in Langerhans cell histiocytosis","volume":"97","author":"Geissman","year":"2001","journal-title":"Blood"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001935","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T17:00:36Z","timestamp":1749747636000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001935"}},"subtitle":["Potential Utility in Diagnosis and Differential Diagnosis"],"short-title":[],"issued":{"date-parts":[[2022,7,26]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001935","relation":{},"ISSN":["0147-5185"],"issn-type":[{"type":"print","value":"0147-5185"}],"subject":[],"published":{"date-parts":[[2022,7,26]]}}}